Cell-To-Cell Communication in Health and Disease
Principal Investigator
Michael Risner, PhD
Oakland University William Beaumont School of Medicine
Rochester, MI, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$196,512
Active Dates
July 01, 2022 - June 30, 2025
Grant ID
G2022011S
Co-Principal Investigator(s)
David Calkins, PhD, Vanderbilt University Medical Center
Goals
The goal of this project is to understand mechanisms of intercellular communication in the context of cell-replacement therapy.
Grantee institution at the time of this grant: Vanderbilt University Medical Center
Summary
Using high-resolution microscopy, we will investigate mitochondrial trafficking through tunneling nanotubes, which are thin protrusions that extend from the plasma membrane, between human embryonic stem cell derived retinal ganglion cells and astrocytes under physiologic (Aim 1) and pathologic conditions (Aim 2).
Unique and Innovative
We are the first to investigate regulatory mechanisms of intercellular mitochondrial transfer in human-derived cells in the context of developing treatments for glaucoma.
Foreseeable Benefits
These studies will explore a potential compensatory pathway for the upregulation of intercellular mitochondrial transfer during stress. We will employ gene-based interventions to reduce and increase intercellular trafficking of mitochondria and determine the influence of each strategy on cell health.
Grants
Related Grants
National Glaucoma Research
Saving Sight: A Journey to Healing Without Scars
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Jennifer Fan Gaskin, FRANZCO
Saving Sight: A Journey to Healing Without Scars
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Jennifer Fan Gaskin, FRANZCO
National Glaucoma Research
Retinal Ganglion Cell Axon Degeneration in a 3D Microfluidic Hydrogel Model
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shruti Patil, PhD
Retinal Ganglion Cell Axon Degeneration in a 3D Microfluidic Hydrogel Model
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shruti Patil, PhD
National Glaucoma Research
Harnessing Artificial Intelligence to Improve Glaucoma Clinical Trials
Active Dates
July 01, 2023 - June 30, 2025
Principal Investigator
Jithin Yohannan, MD, MPH
Harnessing Artificial Intelligence to Improve Glaucoma Clinical Trials
Active Dates
July 01, 2023 - June 30, 2025
Principal Investigator
Jithin Yohannan, MD, MPH